« Back
Home /
Anti-Neuregulin-CRD (Cysteine-Rich Domain, Type III) Antibody

Anti-Neuregulin-CRD (Cysteine-Rich Domain, Type III) Antibody

Item no.	75-226
Manufacturer	Antibodies Incorporated
Amount	100 uL
Category	Oncology Neuroscience Neural Lineage Markers Molecular Targets for Neuroscience Antibodies Immunocytochemistry Primary Antibodies By Organ Breast Cancer Immunoblot Neuronal Cell Markers
Type	Antibody Monoclonal
Format	Liquid
Applications	WB, ICC
Clone	N126B/31
Specific against	Human (Homo sapiens), Rat (Rattus norvegicus)
Host	Mouse
Isotype	IgG2b
Conjugate/Tag	Unconjugated
ECLASS 10.1	42030590
ECLASS 11.0	42030590
UNSPSC	12352203
Alias	Neuregulin 1
Shipping Condition	Cool pack
Available
Manufacturer - Type	Primary Antibody
Manufacturer - Targets	Neuregulin-CRD (Cysteine-rich domain, Type III)
Country of Origin	United States
Shipping Temperature	Shipped on ice packs
Storage Conditions	Aliquot and store at ≤ -20°C for long term storage. For short term storage, store at 2-8°C. For maximum recovery of product, centrifuge the vial prior to removing the cap.
Molecular Weight	30 kDa
Manufacturer - Research Area	Cell Signaling, Growth Factor Signaling
Expiration	24 months from date of receipt
Immunogen	Fusion protein amino acids 1-75 (membrane-associated N-terminus) of human Neuregulin-1 (accession number Q96IB3) produced recombinantly in E. Coli
Immunogen Species	Human
Description	Our Anti-Neuregulin-CRD (Cysteine-rich domain, Type III) mouse monoclonal primary antibody from NeuroMab is produced in-house from hybridoma clone N126B/31. It detects human and rat Neuregulin-CRD (Cysteine-rich domain, Type III), and is purified by Protein A chromatography. It is great for use in ICC, WB.
Target Description	Neuregulin 1 is encoded by the gene NRG1. NRG1 is a member of the neuregulin family. NRG1 is a membrane glycoprotein that mediates cell-cell signaling and plays a critical role in the growth and development of multiple organ systems. NRG1 is expressed in the nervous system, intestine, muscle, and heart. Diseases associated with NRG1 include Schizphrenia 6 and Lung Cancer.
Clonality	Monoclonal
Manufacturer - Specificity	No cross-reactivity reported
Concentration	1 mg/mL
Form	Purified by Protein A chromatography
Buffer	10 mM Tris, 50 mM Sodium Chloride, 0.065% Sodium Azide pH 7.125
Production Notes	Produced by in vitro bioreactor culture of hybridoma line followed by Protein A affinity chromatography. Purified mAbs are >90% specific antibody.
Quality Control	Each new lot of antibody is quality control tested on cells overexpressing target protein and confirmed to give the expected staining pattern.
Quality Control: Application	ICC
Usage Statement	These antibodies are to be used as research laboratory reagents and are not for use as diagnostic or therapeutic reagents in humans.
Manufacturer - Statement	We produce our Neuregulin-CRD (Cysteine-rich domain, Type III) mouse monoclonal primary antibody from hybridoma clone N126B/31. It is great in ICC, WB and is purified by Protein A chromatography.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 uL

available

Delivery expected until 8/28/2025

Express Delivery: Save 15 days

Compare

Add to wishlist

Get an offer